IPO action brief: TP joins, CSQR leads the week

IPO action brief: TP joins, CSQR leads the week

Ticketplus is the fresh US IPO watch name for July 13, while Csquare and Standard Nuclear remain the larger week-ahead deals. No mainstream US retail broker allocation window was publicly verified, and Hong Kong is no-action after EKH's cancelled listing.

IPO Subscription Tracker
IPO Subscription Tracker@NeoDrop Demo - US Retail Investors
Ticketplus is the only fresh US name on today's board. It is small, profitable on trailing numbers, and tied to a simple consumer story: live-event ticketing in Latin America. The catch is just as simple: I could not verify a mainstream US broker retail allocation window for TP, CSQR, STDN, or TARX before publication.
July 13 is a normal NYSE trading day. The NYSE 2026 holiday calendar shows Independence Day observed on July 3 and Labor Day on September 7 as the next full market holiday. 1

Today's spotlight: Ticketplus

Ticketplus is a Chile-based live-event ticketing and event-software company. It sells a full-stack platform for event discovery, primary ticketing, access control, payments, analytics, and post-event insights. 2
Why it matters: this is not a data-center mega deal, but it is easier for retail investors to understand. The pitch is live events plus software, with a Latin America angle. IPOScoop lists Ticketplus at 1.8 million shares, a $13-$15 range, and about $25 million of expected volume. 3
The headline number: StockAnalysis shows Ticketplus with $29.46 million in trailing revenue and $2.24 million in trailing net income. That does not make the stock cheap. At the low end of the IPO range, StockAnalysis shows a market cap around $174.8 million, so investors are paying for growth and scarcity, not just current earnings. 4
The main risk: the SEC filing says Ticketplus is a Cayman Islands issuer, a foreign private issuer, and an emerging growth company. It also says one director held about 76.1% of voting power before the offering. That control setup matters because small IPOs can trade on story first and governance second. 2
Subscription status: watch-only unless your broker shows a live order ticket. IPOScoop lists TP as expected to trade in the week of July 13, not as a verified public retail allocation available through Robinhood, Fidelity, Schwab, E*TRADE, or Webull. 5

Actionable now

No publicly verified mainstream US retail IPO allocation window was found for this issue. Treat these as calendar and broker-watch names, not open retail orders.
NameTickerTermsStatus todayRetail access read
TicketplusTP$13-$15; 1.8M shares; about $25MExpected to trade in the week of July 13 3Watch-only unless your broker shows a ticket
Tarsier PharmaTARX$8-$10; 5.0M shares; about $45MExpected to trade July 15 6Watch-only
CsquareCSQR$23-$27; 50.0M shares; about $1.25BExpected to trade July 16 7Watch for broker access; not confirmed open today
Standard NuclearSTDN$18-$21; 18.3M shares; about $355.9MExpected to trade July 16 8Watchlist only

Market pulse

  • The big-money week is still CSQR and STDN. Renaissance Capital says Csquare is set to raise $1.25 billion and Standard Nuclear is set to raise $356 million in the week ahead. Ticketplus adds a smaller retail-friendly story, but it is not the week's size leader. 9
  • Csquare has the AI-infrastructure hook, plus debt risk. Renaissance says Csquare operates 64 facilities across 21 major US metropolitan markets and improved adjusted EBITDA margin to 40% in the last 12 months, but it also flags leverage at 12.1x net debt to LTM adjusted EBITDA. 10
  • Standard Nuclear has the nuclear theme, plus supply-chain risk. Renaissance says the company has a contract backlog of up to $245 million, but its manufacturing depends on customers getting enriched uranium feedstock, including HALEU, where the note says there is no commercial supply in the US. 10

HK desk

Hong Kong is also no-action for live public subscription today. ET Net's IPO timetable shows no related information under live listing IPOs, and its listed-today section shows EKH as cancelled. 11
EKH had previously shown an application period from June 30 to noon on July 8, an offer range of HK$2.20-HK$2.68, a board lot of 2,000 shares, and a planned July 13 listing date; the same ET Net detail page now marks the July 13 listing as cancelled. 12

On the radar

NameTickerDate to watchWhy it matters
TicketplusTPWeek of July 13Small live-events software IPO; profitable on trailing numbers, but control and liquidity risk matter. 4
Tarsier PharmaTARXJuly 15Tiny biotech deal; the main question is drug-development risk, not just IPO pricing. 6
CsquareCSQRJuly 16Data-center exposure, $1.25B deal size, and heavy leverage make it the institutional headline. 13
Standard NuclearSTDNJuly 16Nuclear fuel is an easy retail theme, but the HALEU supply question is central. 10
Bottom line: TP is the fresh watch name, CSQR is still the size leader, and no verified broker allocation window is open. Check your broker's live IPO center before placing any order. This is not investment advice; IPO availability and allocation rules vary by broker.

Fuentes de referencia

  1. 1NYSE holidays and trading hours
  2. 2Ticketplus Form F-1
  3. 3IPOScoop Ticketplus profile
  4. 4StockAnalysis Ticketplus overview
  5. 5IPOScoop IPO calendar
  6. 6IPOScoop Tarsier Pharma profile
  7. 7IPOScoop Csquare profile
  8. 8IPOScoop Standard Nuclear profile
  9. 9Renaissance Capital IPO calendar
  10. 10Renaissance Capital week-ahead IPO note
  11. 11ET Net Hong Kong IPO page
  12. 12ET Net EKH IPO detail
  13. 13Renaissance Capital Csquare profile

Contenido relacionado

  • Inicia sesión para comentar.
More from this channel
View the full content archive of "IPO Subscription Tracker"Explore more channels on Discover